0 Reacties
0 aandelen
38 Views
0 voorbeeld
Zoeken
Ontdek nieuwe mensen, nieuwe verbindingen te maken en nieuwe vrienden maken
-
Please log in to like, share and comment!
-
The cancer drug that changed everything: why Rituximab is still a blockbuster after 25 yearsFirst approved in 1997, Rituximab (Rituxan) was the first monoclonal antibody for cancer. It targets CD20 on B-cells, killing lymphoma cells while sparing healthy tissue. The rituximab market report by MRFR shows that non-Hodgkin lymphoma (NHL) is the largest indication, but chronic lymphocytic leukemia (CLL) is the fastest‑growing. The market is $34.52 billion and will hit $52.37...0 Reacties 0 aandelen 3 Views 0 voorbeeld
© 2026 Faith World Co
Dutch